Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2023-05-30 Audit Report / Informat…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations")
Audit Report / Information Classification · 95% confidence The document is a detailed disclosure pursuant to SEBI Listing Regulations, including audited standalone and consolidated financial results for the year ended 31 March 2023. It contains the independent auditor's report with an unmodified opinion, detailed audit responsibilities, management and board responsibilities, and audit findings. The document includes substantive financial data and analysis, not just an announcement or summary. It is not a brief press release or a certification letter but a full audit report accompanying the annual financial results. Therefore, it fits the definition of an Audit Report / Information (AR) filing, as it is a standalone audit report separate from the full Annual Report (10-K).
2023-05-30 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the USFDA inspection of the company's manufacturing facility and the issuance of a Form 483 with observations. The document is an intimation or announcement of a regulatory event rather than a detailed report or financial statement. The length is short (1723 characters), and it does not contain financial data or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-05-25 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the USFDA inspection of the company's manufacturing facility and the issuance of Form 483 with observations. The document is an intimation or announcement of a regulatory event rather than a detailed report or financial statement. The length is short (1723 characters), and it serves as a notification to the exchanges about a material event. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-05-25 English
Annual Secretarial Compliance Report
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report for the year ended 31-Mar-23' and is issued pursuant to SEBI regulations. It is a detailed compliance report by a practicing company secretary regarding the company's adherence to statutory provisions and corporate governance practices for the financial year ended March 31, 2023. The document includes references to SEBI regulations, compliance status, and auditor resignation matters. It is not an annual report, audit report, or earnings release, but a secretarial compliance report which is a regulatory compliance document. This type of document fits best under Regulatory Filings (RNS) as it is a compliance report submitted to stock exchanges and regulatory bodies, and does not constitute a financial report or management report itself.
2023-05-24 English
Pursuant to Regulation 24A(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 08-Feb-19 and BSE and ....
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report for the year ended 31-Mar-23' and is issued pursuant to SEBI regulations. It is a detailed compliance report by a practicing company secretary reviewing the company's adherence to statutory provisions and corporate governance practices for the financial year ended March 31, 2023. The content includes examination of filings, regulatory compliance, and auditor resignation status, which are typical elements of a secretarial compliance report rather than a full annual report or audit report. The document is not a brief announcement or a certification letter but a substantive compliance report. Therefore, it fits best under the category of Regulatory Filings (RNS) as it is a regulatory compliance report that does not fall under other specific categories like Annual Report or Audit Report.
2023-05-24 English
Scheme of Arrangement
M&A Activity Classification · 95% confidence The document is a formal letter addressed to the stock exchanges (BSE and NSE) regarding an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the sanction of a Scheme of Arrangement (Amalgamation) by the National Company Law Tribunal (NCLT). The letter references a previous communication about the Board's approval of the Scheme and states that the Scheme will become effective upon filing with the Registrar of Companies. The document is an announcement of a corporate action related to merger/amalgamation but does not contain detailed merger documents or tender offer filings. It is not a full merger filing (MA) but an update on M&A activity. Given the content and context, this fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length is short and it is an announcement, not a full report or filing. Therefore, the classification is M&A Activity (TAR) with high confidence.
2023-05-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.